Equine Veterinary Pharmaceuticals Market Expected to Reach USD 2.93...

Autres

Equine Veterinary Pharmaceuticals Market Expected to Reach USD 2.93 Billion by 2031 as Preventive Care and Performance Drug Use Expand Across Competitive Equine Sectors

2025-05-19 13:53:57 • Lectures

[Lexington, KY – May 19th, 2025] – According to Clearview Market Insights, the global Equine Veterinary Pharmaceuticals Market, currently valued at USD 1.8 billion, is projected to reach USD 2.93 billion by 2031, expanding at a CAGR of 7.2%. This growth is driven by increased veterinary intervention in sports horses, rising demand for geriatric care, and enhanced compliance tools for drug delivery.

Request Sample @ https://clearviewmarketinsights.com/report-details/equine-veterinary-pharmaceuticals-market/

2024 Industry Milestones

Racehorse Therapy Innovation

Dechra launches once-a-month injectable NSAID for chronic joint pain.
Zoetis releases an oral anti-ulcer gel with zero-day withdrawal for show horses.

Digital Vet Solutions Integrated with Pharmacies

North America sees rise in tele-vet platforms linked to automated prescription refills.

Regulatory Updates Improve Transparency

FEI and U.S. Racing authorities enforce new digital drug logging systems.
Japan Racing Association approves two new anti-inflammatory drugs.

Executive Insights

"Horses are elite athletes with complex needs. Precision pharma, fast-acting relief, and strict compliance are redefining how veterinary care is delivered," said Dr. Alan Crowe, Senior Equine Pharmacology Analyst at Clearview Market Insights.

"The future lies in long-acting therapies, companion apps for monitoring, and zero-residue medications that don't compromise sport integrity," added Samantha Yuen, Global Equine Strategy Director, Zoetis.

Roadmap to 2031

2025: First AI-powered dosing system integrated with wearables
2026: Fully FEI-compliant, race-safe anti-inflammatory portfolios become standard
2028: 40% of equine medications delivered via sustained-release or transdermal methods
2030: Personalized pharmaceutical plans based on genetics and digital health history
2031: AI-informed vet-pharma cloud platforms manage 70% of prescriptions globally

For more insights, visit https://clearviewmarketinsights.com/

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

#Equine_Veterinary_Pharmaceuticals_Market

Veuillez vous connecter pour apprécier, partager et commenter!

Equine Veterinary Pharmaceuticals Market Expected to Reach USD 2.93 Billion by 2031 as Preventive Care and Performance Drug Use Expand Across Competitive Equine Sectors

Fine Arts Logistics Market, Share, Trends, Growth Factors, Regional Segment Revenue Analysis, For 2032

Healthcare Artificial Intelligence Market Size, Share, Trends, Industry Leading Players, and Opportunity Assessment for the Period of 2023-2032

Connexion

Langue

Equine Veterinary Pharmaceuticals Market Expected to Reach USD 2.93 Billion by 2031 as Preventive Care and Performance Drug Use Expand Across Competitive Equine Sectors

Fine Arts Logistics Market, Share, Trends, Growth Factors, Regional Segment Revenue Analysis, For 2032

Healthcare Artificial Intelligence Market Size, Share, Trends, Industry Leading Players, and Opportunity Assessment for the Period of 2023-2032